GLP-1 Drug Plaintiffs Denied Early Discovery Into Defendants’ Marketing Campaigns



DOCUMENTS
  • Order


PHILADELPHIA — The judge overseeing the MDL docket for GLP-RA drug lawsuits has denied plaintiffs’ request to allow early discovery into defendants’ marketing campaigns to physicians, noting the court has already considered and rejected the motion, agreeing with defendants that discovery on only a few key issues was appropriate.

In an Oct. 17 order, Judge Karen S. Marston of the U.S. District Court for the Eastern District of Pennsylvania rejected plaintiffs’ argument that marketing discovery of any kind is relevant to early discovery and motion practice on the issues of failure to warn and preemption.

“As the Court has …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

December 04, 2024 - New York, NY
Virgin Hotels NYC

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS